Barclays Maintains Equal-Weight on HCA Healthcare, Raises Price Target to $300
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Steve Valiquette has maintained an Equal-Weight rating on HCA Healthcare (NYSE:HCA) and raised the price target from $275 to $300.
June 28, 2023 | 12:39 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Barclays has maintained an Equal-Weight rating on HCA Healthcare and raised the price target from $275 to $300. This could potentially lead to an increase in the stock's price.
The raised price target by Barclays indicates a positive outlook for HCA Healthcare. This could lead to increased investor confidence and potentially an increase in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100